OR WAIT 15 SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
October 15, 2016
BioPharm International spoke with Selexis CEO and Chairman Igor Fisch, PhD about the latest cell-line development advances.
Are investigations supporting or hindering performance excellence?
Designing systems using the principles of good documentation practice, including validated audit trails, is a key piece of a manufacturing data integrity program.
A technology management process identifies and evaluates new technologies in biopharmaceutical manufacturing to aid business decisions.
The authors describe the qualification of an assay with applications for investigating functional comparability of an originator and biosimilar drug.
Plant transient expression offers a flexible approach in drug development and enables rapid production and scale up of therapeutics.
Experts discuss recent advances in cell viability testing methods in bioreactors.